HEADER SIGNALING PROTEIN/PEPTIDE 09-FEB-12 4AIF TITLE AIP TPR DOMAIN IN COMPLEX WITH HUMAN HSP90 PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: AH RECEPTOR-INTERACTING PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: TETRATRICOPEPTIDE DOMAIN, RESIDUES 172-315; COMPND 5 SYNONYM: AIP, ARYL-HYDROCARBON RECEPTOR-INTERACTING PROTEIN, HBV COMPND 6 X-ASSOCIATED PROTEIN 2, XAP-2, IMMUNOPHILIN HOMOLOG ARA9; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: HEAT SHOCK PROTEIN HSP 90-ALPHA; COMPND 11 CHAIN: D, E; COMPND 12 FRAGMENT: C-TERMINAL PEPTIDE SRMEEVD, RESIDUES 726-732; COMPND 13 SYNONYM: HEAT SHOCK 86 KDA, HSP 86, HSP86, RENAL CARCINOMA ANTIGEN COMPND 14 NY-REN-38 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PTWO-E; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606 KEYWDS SIGNALING PROTEIN-PEPTIDE COMPLEX, ARYL HYDROCARBON RECEPTOR EXPDTA X-RAY DIFFRACTION AUTHOR R.M.L.MORGAN,S.M.ROE,L.H.PEARL,C.PRODROMOU REVDAT 1 23-JAN-13 4AIF 0 JRNL AUTH R.M.MORGAN,L.C.HERNANDEZ-RAMIREZ,G.TRIVELLIN,L.ZHOU,S.M.ROE, JRNL AUTH 2 M.KORBONITS,C.PRODROMOU JRNL TITL STRUCTURE OF THE TPR DOMAIN OF AIP: LACK OF CLIENT PROTEIN JRNL TITL 2 INTERACTION WITH THE C-TERMINAL ALPHA-7 HELIX OF THE TPR JRNL TITL 3 DOMAIN OF AIP IS SUFFICIENT FOR PITUITARY ADENOMA JRNL TITL 4 PREDISPOSITION. JRNL REF PLOS ONE V. 7 53339 2012 JRNL REFN ISSN 1932-6203 JRNL PMID 23300914 JRNL DOI 10.1371/JOURNAL.PONE.0053339 REMARK 2 REMARK 2 RESOLUTION. 2.01 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VICENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : MLHL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.006 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.405 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.40 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.40 REMARK 3 NUMBER OF REFLECTIONS : 29971 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.1903 REMARK 3 R VALUE (WORKING SET) : 0.1879 REMARK 3 FREE R VALUE : 0.2360 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.1 REMARK 3 FREE R VALUE TEST SET COUNT : 1519 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 40.4134 - 4.4601 0.98 2600 143 0.1809 0.2254 REMARK 3 2 4.4601 - 3.5408 0.99 2599 131 0.1551 0.1969 REMARK 3 3 3.5408 - 3.0934 1.00 2607 143 0.1750 0.2120 REMARK 3 4 3.0934 - 2.8107 1.00 2612 127 0.1865 0.2334 REMARK 3 5 2.8107 - 2.6092 1.00 2599 129 0.1901 0.2737 REMARK 3 6 2.6092 - 2.4554 1.00 2566 132 0.2041 0.2269 REMARK 3 7 2.4554 - 2.3325 1.00 2593 157 0.2060 0.2864 REMARK 3 8 2.3325 - 2.2309 1.00 2571 127 0.2088 0.2667 REMARK 3 9 2.2309 - 2.1451 0.99 2601 135 0.2168 0.2524 REMARK 3 10 2.1451 - 2.0711 0.99 2545 153 0.2435 0.2846 REMARK 3 11 2.0711 - 2.0063 0.99 2559 142 0.2839 0.3514 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.381 REMARK 3 B_SOL : 70.129 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.29 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.72 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.62 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.03 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.9602 REMARK 3 B22 (A**2) : -0.1022 REMARK 3 B33 (A**2) : -2.8579 REMARK 3 B12 (A**2) : 0.0000 REMARK 3 B13 (A**2) : 1.0990 REMARK 3 B23 (A**2) : 0.0000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 2461 REMARK 3 ANGLE : 0.960 3351 REMARK 3 CHIRALITY : 0.070 372 REMARK 3 PLANARITY : 0.004 437 REMARK 3 DIHEDRAL : 13.170 918 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESIDUES 172-176 AND 312-315 ARE REMARK 3 DISORDERED REMARK 4 REMARK 4 4AIF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 09-FEB-12. REMARK 100 THE PDBE ID CODE IS EBI-51240. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-SEP-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : L REMARK 200 WAVELENGTH OR RANGE (A) : 0.9763 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL (PILATUS) REMARK 200 DETECTOR MANUFACTURER : DECTRIS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29974 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.01 REMARK 200 RESOLUTION RANGE LOW (A) : 40.41 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NONE REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 3.2 REMARK 200 R MERGE (I) : 0.06 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.90 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.01 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 8.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.2 REMARK 200 R MERGE FOR SHELL (I) : 0.59 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.40 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER FOR MR REMARK 200 STARTING MODEL: TPR HOMOLOGY MODEL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.4 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1 M AMMONIUM SULFATE, 0.1 M REMARK 280 BIS-TRIS PH 5.5, 1% PEG 3350 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 31.91000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 52.24500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 31.91000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 52.24500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 960 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8700 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.8 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 890 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8480 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -3.8 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2076 LIES ON A SPECIAL POSITION. REMARK 375 HOH E2010 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, GLU 172 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN B, GLU 172 TO ALA REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 184 CG CD OE1 NE2 REMARK 470 ASN A 211 ND2 REMARK 470 LYS A 215 CD CE NZ REMARK 470 GLU A 222 CG CD OE1 OE2 REMARK 470 GLN A 225 CD OE1 NE2 REMARK 470 GLN A 228 OE1 NE2 REMARK 470 GLN A 282 CD OE1 NE2 REMARK 470 GLU A 310 CG CD OE1 OE2 REMARK 470 ARG A 314 NE CZ NH1 NH2 REMARK 470 GLU B 174 CG CD OE1 OE2 REMARK 470 GLN B 184 CG CD OE1 NE2 REMARK 470 ASN B 211 ND2 REMARK 470 LYS B 215 CD CE NZ REMARK 470 GLU B 222 CG CD OE1 OE2 REMARK 470 GLN B 225 CG CD OE1 NE2 REMARK 470 GLN B 282 CD OE1 NE2 REMARK 470 GLN B 285 CG CD OE1 NE2 REMARK 470 LYS B 290 NZ REMARK 470 GLN B 307 CD OE1 NE2 REMARK 470 GLU B 310 CG CD OE1 OE2 REMARK 470 ARG B 314 NE CZ NH1 NH2 REMARK 470 ARG D 2 NE CZ NH1 NH2 REMARK 470 GLU D 4 CG CD OE1 OE2 REMARK 470 ARG E 2 CG CD NE CZ NH1 NH2 REMARK 470 GLU E 4 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 173 -20.80 -169.72 REMARK 500 ALA A 297 -9.89 -59.16 REMARK 500 GLU B 173 -7.83 -147.80 REMARK 500 LYS B 175 34.94 -84.39 REMARK 500 ARG B 314 -103.61 -107.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH E2009 DISTANCE = 9.39 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A1316 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BYQ RELATED DB: PDB REMARK 900 HSP90 N-TERMINAL DOMAIN BOUND TO ADP-MG REMARK 900 RELATED ID: 1OSF RELATED DB: PDB REMARK 900 HUMAN HSP90 IN COMPLEX WITH 17-DESMETHOXY-17-N,N- REMARK 900 DIMETHYLAMINOETHYLAMINO-GELDANAMYCIN REMARK 900 RELATED ID: 1UY6 RELATED DB: PDB REMARK 900 HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(3,4,5-TRIMETHOXY REMARK 900 -BENZYL)-9H-PURIN-6-YLAMINE REMARK 900 RELATED ID: 1UY7 RELATED DB: PDB REMARK 900 HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(4-METHOXY-BENZYL REMARK 900 )-9H-PURIN-6-YLAMINE REMARK 900 RELATED ID: 1UY8 RELATED DB: PDB REMARK 900 HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(3-TRIMETHOXY- REMARK 900 BENZYL)-9H-PURIN-6YLAMINE REMARK 900 RELATED ID: 1UY9 RELATED DB: PDB REMARK 900 HUMAN HSP90-ALPHA WITH 8-BENZO[1,3]DIOXOL-,5- REMARK 900 YLMETHYL-9-BUTYL-9H-PURIN-6-YLAMINE REMARK 900 RELATED ID: 1UYC RELATED DB: PDB REMARK 900 HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(2,5-DIMETHOXY- REMARK 900 BENZYL)-9H-PURIN-6-YLAMINE REMARK 900 RELATED ID: 1UYD RELATED DB: PDB REMARK 900 HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(2-CHLORO-3,4,5 REMARK 900 -TRIMETHOXY-BENZYL)-9H-PURIN-6-YLAMINE REMARK 900 RELATED ID: 1UYE RELATED DB: PDB REMARK 900 HUMAN HSP90-ALPHA WITH 8-(2-CHLORO-3,4,5- REMARK 900 TRIMETHOXY-BENZYL)-9-PENT-4-YLNYL-9H-PURIN-6-YLAMINE REMARK 900 RELATED ID: 1UYF RELATED DB: PDB REMARK 900 HUMAN HSP90-ALPHA WITH 8-(2-CHLORO-3,4,5- REMARK 900 TRIMETHOXY-BENZYL)-2-FLUORO-9-PENT-4-YLNYL-9H-PURIN REMARK 900 -6-YLAMINE REMARK 900 RELATED ID: 1UYG RELATED DB: PDB REMARK 900 HUMAN HSP90-ALPHA WITH 8-(2,5-DIMETHOXY-BENZYL)-2- REMARK 900 FLUORO-9H-PURIN-6-YLAMINE REMARK 900 RELATED ID: 1UYH RELATED DB: PDB REMARK 900 HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(2,5-DIMETHOXY- REMARK 900 BENZYL)-2-FLUORO-9H-PURIN-6-YLAMINE REMARK 900 RELATED ID: 1UYI RELATED DB: PDB REMARK 900 HUMAN HSP90-ALPHA WITH 8-(2,5-DIMETHOXY-BENZYL)-2- REMARK 900 FLUORO-9-PENT-9H-PURIN-6-YLAMINE REMARK 900 RELATED ID: 1UYK RELATED DB: PDB REMARK 900 HUMAN HSP90-ALPHA WITH 8-BENZO[1,3]DIOXOL-,5- REMARK 900 YLMETHYL-9-BUTYL-2-FLUORO-9H-PURIN-6-YLAMINE REMARK 900 RELATED ID: 1UYL RELATED DB: PDB REMARK 900 STRUCTURE-ACTIVITY RELATIONSHIPS IN PURINE-BASED INHIBITOR REMARK 900 BINDING TO HSP90 ISOFORMS REMARK 900 RELATED ID: 1YC1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF HUMAN HSP90ALPHA COMPLEXED REMARK 900 WITHDIHYDROXYPHENYLPYRAZOLES REMARK 900 RELATED ID: 1YC3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN HSP90ALPHA COMPLEXED REMARK 900 WITHDIHYDROXYPHENYLPYRAZOLES REMARK 900 RELATED ID: 1YC4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN HSP90ALPHA COMPLEXED REMARK 900 WITHDIHYDROXYPHENYLPYRAZOLES REMARK 900 RELATED ID: 1YER RELATED DB: PDB REMARK 900 HUMAN HSP90 GELDANAMYCIN-BINDING DOMAIN, "CLOSED" REMARK 900 CONFORMATION REMARK 900 RELATED ID: 1YES RELATED DB: PDB REMARK 900 HUMAN HSP90 GELDANAMYCIN-BINDING DOMAIN, "OPEN" REMARK 900 CONFORMATION REMARK 900 RELATED ID: 1YET RELATED DB: PDB REMARK 900 GELDANAMYCIN BOUND TO THE HSP90 GELDANAMYCIN-BINDING REMARK 900 DOMAIN REMARK 900 RELATED ID: 2BSM RELATED DB: PDB REMARK 900 NOVEL, POTENT SMALL MOLECULE INHIBITORS OF THE MOLECULAR REMARK 900 CHAPERONE HSP90 DISCOVERED THROUGH STRUCTURE-BASED REMARK 900 DESIGN REMARK 900 RELATED ID: 2BT0 RELATED DB: PDB REMARK 900 NOVEL, POTENT SMALL MOLECULE INHIBITORS OF THE MOLECULAR REMARK 900 CHAPERONE HSP90 DISCOVERED THROUGH STRUCTURE-BASED REMARK 900 DESIGN REMARK 900 RELATED ID: 2BUG RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE TPR DOMAIN FROM PROTEIN REMARK 900 PHOSPHATASE 5 IN COMPLEX WITH HSP90 DERIVED PEPTIDE REMARK 900 RELATED ID: 2BYH RELATED DB: PDB REMARK 900 3-(5-CHLORO-2,4-DIHYDROXYPHENYL)-PYRAZOLE-4- REMARK 900 CARBOXAMIDES AS INHIBITORS OF THE HSP90 MOLECULAR REMARK 900 CHAPERONE REMARK 900 RELATED ID: 2BYI RELATED DB: PDB REMARK 900 3-(5-CHLORO-2,4-DIHYDROXYPHENYL)-PYRAZOLE-4- REMARK 900 CARBOXAMIDES AS INHIBITORS OF THE HSP90 MOLECULAR REMARK 900 CHAPERONE REMARK 900 RELATED ID: 2BZ5 RELATED DB: PDB REMARK 900 STRUCTURE-BASED DISCOVERY OF A NEW CLASS OF HSP90 REMARK 900 INHIBITORS REMARK 900 RELATED ID: 2C2L RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CHIP U-BOX E3 UBIQUITIN REMARK 900 LIGASE REMARK 900 RELATED ID: 2CCS RELATED DB: PDB REMARK 900 HUMAN HSP90 WITH 4-CHLORO-6-(4-PIPERAZIN-1-YL-1H- REMARK 900 PYRAZOL-3-YL)-BENZENE-1,2-DIOL REMARK 900 RELATED ID: 2CCT RELATED DB: PDB REMARK 900 HUMAN HSP90 WITH 5-(5-CHLORO-2,4-DIHYDROXY-PHENYL)- REMARK 900 4-PIPERAZIN-1-YL-2H-PYRAZOLE-3-CARBOXYLIC ACID REMARK 900 ETHYLAMIDE REMARK 900 RELATED ID: 2CCU RELATED DB: PDB REMARK 900 HUMAN HSP90 WITH 4-CHLORO-6-(4-(4-(4- REMARK 900 METHANESULPHONYL-BENZYL)-PIERAZIN-1-YL)-1H-PYRAZOL-3- REMARK 900 YL)-BENZENE-1,3-DIOL REMARK 900 RELATED ID: 2CDD RELATED DB: PDB REMARK 900 HUMAN HSP90 WITH 4-(4-(2,3-DIHYDRO-BENZOL(1,4) REMARK 900 DIOXIN-6-YL)-5-METHYL-1H-PYRAZOL-3-YL)-6-ETHYL- REMARK 900 BENZENE-1,3-DIOL REMARK 900 RELATED ID: 2FWY RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN HSP90-ALPHA BOUND TO THE POTENT REMARK 900 WATERSOLUBLE INHIBITOR PU-H64 REMARK 900 RELATED ID: 2FWZ RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN HSP90-ALPHA BOUND TO THE POTENT REMARK 900 WATERSOLUBLE INHIBITOR PU-H71 REMARK 900 RELATED ID: 2JJC RELATED DB: PDB REMARK 900 HSP90 ALPHA ATPASE DOMAIN WITH BOUND SMALL MOLECULE REMARK 900 FRAGMENT REMARK 900 RELATED ID: 2UWD RELATED DB: PDB REMARK 900 INHIBITION OF THE HSP90 MOLECULAR CHAPERONE IN VITRO REMARK 900 AND IN VIVO BY NOVEL, SYNTHETIC, POTENT RESORCINYLIC REMARK 900 PYRAZOLE, ISOXAZOLE AMIDE ANALOGS REMARK 900 RELATED ID: 2VCI RELATED DB: PDB REMARK 900 4,5 DIARYL ISOXAZOLE HSP90 CHAPERONE INHIBITORS: REMARK 900 POTENTIAL THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER REMARK 900 RELATED ID: 2VCJ RELATED DB: PDB REMARK 900 4,5 DIARYL ISOXAZOLE HSP90 CHAPERONE INHIBITORS: REMARK 900 POTENTIAL THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER REMARK 900 RELATED ID: 2WI1 RELATED DB: PDB REMARK 900 ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE REMARK 900 HSP90 CHAPERONE REMARK 900 RELATED ID: 2WI2 RELATED DB: PDB REMARK 900 ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE REMARK 900 HSP90 CHAPERONE REMARK 900 RELATED ID: 2WI3 RELATED DB: PDB REMARK 900 ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE REMARK 900 HSP90 CHAPERONE REMARK 900 RELATED ID: 2WI4 RELATED DB: PDB REMARK 900 ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE REMARK 900 HSP90 CHAPERONE REMARK 900 RELATED ID: 2WI5 RELATED DB: PDB REMARK 900 ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE REMARK 900 HSP90 CHAPERONE REMARK 900 RELATED ID: 2WI6 RELATED DB: PDB REMARK 900 ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE REMARK 900 HSP90 CHAPERONE REMARK 900 RELATED ID: 2WI7 RELATED DB: PDB REMARK 900 ORALLY ACTIVE 2-AMINO THIENOPYRIMIDINE INHIBITORS OF THE REMARK 900 HSP90 CHAPERONE REMARK 900 RELATED ID: 2XAB RELATED DB: PDB REMARK 900 STRUCTURE OF HSP90 WITH AN INHIBITOR BOUND REMARK 900 RELATED ID: 2XDK RELATED DB: PDB REMARK 900 STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND REMARK 900 RELATED ID: 2XDL RELATED DB: PDB REMARK 900 STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND REMARK 900 RELATED ID: 2XDS RELATED DB: PDB REMARK 900 STRUCTRE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND REMARK 900 RELATED ID: 2XDU RELATED DB: PDB REMARK 900 STRUCTRE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND REMARK 900 RELATED ID: 2XDX RELATED DB: PDB REMARK 900 STRUCTRE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND REMARK 900 RELATED ID: 2XHR RELATED DB: PDB REMARK 900 STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND REMARK 900 RELATED ID: 2XHT RELATED DB: PDB REMARK 900 STRUCTRE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND REMARK 900 RELATED ID: 2XHX RELATED DB: PDB REMARK 900 STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND REMARK 900 RELATED ID: 2XJG RELATED DB: PDB REMARK 900 STRUCTURE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND REMARK 900 RELATED ID: 2XJJ RELATED DB: PDB REMARK 900 STRUCTRE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND REMARK 900 RELATED ID: 2XJX RELATED DB: PDB REMARK 900 STRUCTRE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND REMARK 900 RELATED ID: 2XK2 RELATED DB: PDB REMARK 900 STRUCTRE OF HSP90 WITH SMALL MOLECULE INHIBITOR BOUND REMARK 900 RELATED ID: 2YE2 RELATED DB: PDB REMARK 900 HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL REMARK 900 SCREENING REMARK 900 RELATED ID: 2YE3 RELATED DB: PDB REMARK 900 HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL REMARK 900 SCREENING REMARK 900 RELATED ID: 2YE4 RELATED DB: PDB REMARK 900 HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL REMARK 900 SCREENING REMARK 900 RELATED ID: 2YE5 RELATED DB: PDB REMARK 900 HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL REMARK 900 SCREENING REMARK 900 RELATED ID: 2YE6 RELATED DB: PDB REMARK 900 HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL REMARK 900 SCREENING REMARK 900 RELATED ID: 2YE7 RELATED DB: PDB REMARK 900 HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL REMARK 900 SCREENING REMARK 900 RELATED ID: 2YE8 RELATED DB: PDB REMARK 900 HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL REMARK 900 SCREENING REMARK 900 RELATED ID: 2YE9 RELATED DB: PDB REMARK 900 HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL REMARK 900 SCREENING REMARK 900 RELATED ID: 2YEA RELATED DB: PDB REMARK 900 HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL REMARK 900 SCREENING REMARK 900 RELATED ID: 2YEB RELATED DB: PDB REMARK 900 HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL REMARK 900 SCREENING REMARK 900 RELATED ID: 2YEC RELATED DB: PDB REMARK 900 HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL REMARK 900 SCREENING REMARK 900 RELATED ID: 2YED RELATED DB: PDB REMARK 900 HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL REMARK 900 SCREENING REMARK 900 RELATED ID: 2YEE RELATED DB: PDB REMARK 900 HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL REMARK 900 SCREENING REMARK 900 RELATED ID: 2YEF RELATED DB: PDB REMARK 900 HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL REMARK 900 SCREENING REMARK 900 RELATED ID: 2YEG RELATED DB: PDB REMARK 900 HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL REMARK 900 SCREENING REMARK 900 RELATED ID: 2YEH RELATED DB: PDB REMARK 900 HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL REMARK 900 SCREENING REMARK 900 RELATED ID: 2YEI RELATED DB: PDB REMARK 900 HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL REMARK 900 SCREENING REMARK 900 RELATED ID: 2YEJ RELATED DB: PDB REMARK 900 HSP90 INHIBITORS AND DRUGS FROM FRAGMENT AND VIRTUAL REMARK 900 SCREENING REMARK 900 RELATED ID: 2YI0 RELATED DB: PDB REMARK 900 STRUCTURAL CHARACTERIZATION OF 5-ARYL-4-(5-SUBSTITUTED- REMARK 900 2-4-DIHYDROXYPHENYL)-1,2,3-THIADIAZOLE HSP90 REMARK 900 INHIBITORS. REMARK 900 RELATED ID: 2YI5 RELATED DB: PDB REMARK 900 STRUCTURAL CHARACTERIZATION OF 5-ARYL-4-(5-SUBSTITUTED- REMARK 900 2-4-DIHYDROXYPHENYL)-1,2,3-THIADIAZOLE HSP90 REMARK 900 INHIBITORS. REMARK 900 RELATED ID: 2YI6 RELATED DB: PDB REMARK 900 STRUCTURAL CHARACTERIZATION OF 5-ARYL-4-(5-SUBSTITUTED- REMARK 900 2-4-DIHYDROXYPHENYL)-1,2,3-THIADIAZOLE HSP90 REMARK 900 INHIBITORS. REMARK 900 RELATED ID: 2YI7 RELATED DB: PDB REMARK 900 STRUCTURAL CHARACTERIZATION OF 5-ARYL-4-(5-SUBSTITUTED- REMARK 900 2-4-DIHYDROXYPHENYL)-1,2,3-THIADIAZOLE HSP90 REMARK 900 INHIBITORS. REMARK 900 RELATED ID: 2YJW RELATED DB: PDB REMARK 900 TRICYCLIC SERIES OF HSP90 INHIBITORS REMARK 900 RELATED ID: 2YJX RELATED DB: PDB REMARK 900 TRICYCLIC SERIES OF HSP90 INHIBITORS REMARK 900 RELATED ID: 2YK2 RELATED DB: PDB REMARK 900 TRICYCLIC SERIES OF HSP90 INHIBITORS REMARK 900 RELATED ID: 2YK9 RELATED DB: PDB REMARK 900 TRICYCLIC SERIES OF HSP90 INHIBITORS REMARK 900 RELATED ID: 2YKB RELATED DB: PDB REMARK 900 TRICYCLIC SERIES OF HSP90 INHIBITORS REMARK 900 RELATED ID: 2YKC RELATED DB: PDB REMARK 900 TRICYCLIC SERIES OF HSP90 INHIBITORS REMARK 900 RELATED ID: 2YKE RELATED DB: PDB REMARK 900 TRICYCLIC SERIES OF HSP90 INHIBITORS REMARK 900 RELATED ID: 2YKI RELATED DB: PDB REMARK 900 TRICYCLIC SERIES OF HSP90 INHIBITORS REMARK 900 RELATED ID: 2YKJ RELATED DB: PDB REMARK 900 TRICYCLIC SERIES OF HSP90 INHIBITORS DBREF 4AIF A 172 315 UNP O00170 AIP_HUMAN 172 315 DBREF 4AIF B 172 315 UNP O00170 AIP_HUMAN 172 315 DBREF 4AIF D 1 7 UNP P07900 HS90A_HUMAN 726 732 DBREF 4AIF E 1 7 UNP P07900 HS90A_HUMAN 726 732 SEQADV 4AIF ALA A 172 UNP O00170 GLU 172 ENGINEERED MUTATION SEQADV 4AIF ALA B 172 UNP O00170 GLU 172 ENGINEERED MUTATION SEQRES 1 A 144 ALA GLU GLU LYS ALA LYS ALA VAL PRO LEU ILE HIS GLN SEQRES 2 A 144 GLU GLY ASN ARG LEU TYR ARG GLU GLY HIS VAL LYS GLU SEQRES 3 A 144 ALA ALA ALA LYS TYR TYR ASP ALA ILE ALA CYS LEU LYS SEQRES 4 A 144 ASN LEU GLN MET LYS GLU GLN PRO GLY SER PRO GLU TRP SEQRES 5 A 144 ILE GLN LEU ASP GLN GLN ILE THR PRO LEU LEU LEU ASN SEQRES 6 A 144 TYR CYS GLN CYS LYS LEU VAL VAL GLU GLU TYR TYR GLU SEQRES 7 A 144 VAL LEU ASP HIS CYS SER SER ILE LEU ASN LYS TYR ASP SEQRES 8 A 144 ASP ASN VAL LYS ALA TYR PHE LYS ARG GLY LYS ALA HIS SEQRES 9 A 144 ALA ALA VAL TRP ASN ALA GLN GLU ALA GLN ALA ASP PHE SEQRES 10 A 144 ALA LYS VAL LEU GLU LEU ASP PRO ALA LEU ALA PRO VAL SEQRES 11 A 144 VAL SER ARG GLU LEU GLN ALA LEU GLU ALA ARG ILE ARG SEQRES 12 A 144 GLN SEQRES 1 B 144 ALA GLU GLU LYS ALA LYS ALA VAL PRO LEU ILE HIS GLN SEQRES 2 B 144 GLU GLY ASN ARG LEU TYR ARG GLU GLY HIS VAL LYS GLU SEQRES 3 B 144 ALA ALA ALA LYS TYR TYR ASP ALA ILE ALA CYS LEU LYS SEQRES 4 B 144 ASN LEU GLN MET LYS GLU GLN PRO GLY SER PRO GLU TRP SEQRES 5 B 144 ILE GLN LEU ASP GLN GLN ILE THR PRO LEU LEU LEU ASN SEQRES 6 B 144 TYR CYS GLN CYS LYS LEU VAL VAL GLU GLU TYR TYR GLU SEQRES 7 B 144 VAL LEU ASP HIS CYS SER SER ILE LEU ASN LYS TYR ASP SEQRES 8 B 144 ASP ASN VAL LYS ALA TYR PHE LYS ARG GLY LYS ALA HIS SEQRES 9 B 144 ALA ALA VAL TRP ASN ALA GLN GLU ALA GLN ALA ASP PHE SEQRES 10 B 144 ALA LYS VAL LEU GLU LEU ASP PRO ALA LEU ALA PRO VAL SEQRES 11 B 144 VAL SER ARG GLU LEU GLN ALA LEU GLU ALA ARG ILE ARG SEQRES 12 B 144 GLN SEQRES 1 D 7 SER ARG MET GLU GLU VAL ASP SEQRES 1 E 7 SER ARG MET GLU GLU VAL ASP HET SO4 A1316 5 HETNAM SO4 SULFATE ION FORMUL 5 SO4 O4 S 2- FORMUL 6 HOH *325(H2 O) HELIX 1 1 LYS A 177 GLY A 193 1 17 HELIX 2 2 HIS A 194 LYS A 215 1 22 HELIX 3 3 SER A 220 VAL A 244 1 25 HELIX 4 4 TYR A 247 TYR A 261 1 15 HELIX 5 5 ASN A 264 VAL A 278 1 15 HELIX 6 6 ASN A 280 ASP A 295 1 16 HELIX 7 7 LEU A 298 ARG A 314 1 17 HELIX 8 8 GLU B 173 ALA B 176 5 4 HELIX 9 9 LYS B 177 GLU B 192 1 16 HELIX 10 10 HIS B 194 MET B 214 1 21 HELIX 11 11 SER B 220 VAL B 244 1 25 HELIX 12 12 GLU B 246 TYR B 261 1 16 HELIX 13 13 ASN B 264 VAL B 278 1 15 HELIX 14 14 ASN B 280 ASP B 295 1 16 HELIX 15 15 LEU B 298 ARG B 312 1 15 SITE 1 AC1 4 ARG A 304 GLN A 307 HOH A2142 GLN B 307 CRYST1 63.820 104.490 69.270 90.00 97.41 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015669 0.000000 0.002038 0.00000 SCALE2 0.000000 0.009570 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014558 0.00000 MASTER 558 0 1 15 0 0 1 6 0 0 0 26 END